Analyst
NEO Wealth Management
Equibles does not estimate personal net worth.
Surichi Parmar is recorded as Analyst at NEO Wealth Management. Surichi Parmar has spoken on 1 earnings call across 1 company, most recently for Beta Drugs Limited on May 15, 2026. The companies whose calls Surichi Parmar spoke on are classified in the Healthcare sector.
“Just in last call, because of this reduction of platen sales, you have already revised your guidance for FI 26 to 420 crores, 400 to 420 crores. But now you have closed the whole year at 385 crores, and EBITDA margins also declined.”
NEO Wealth Management
Analyst
Transcript header (unverified)
Beta Drugs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Beta Drugs Limited
